May 14, 2019 / 7:55 AM / 2 months ago

BRIEF-MolMed Q1 Net Loss Narrows To EUR 0.7‍​ Mln

May 14 (Reuters) - MolMed SpA:

* REPORTED ON MONDAY Q1 OPERATING REVENUE EUR 7.9‍​ MLN VS EUR 5.8 MLN YEAR AGO

* Q1 NET LOSS EUR 0.7‍​ MLN VS LOSS EUR 1.2 MLN YEAR AGO

* SAID GOALS FOR 2019 REMAIN DOUBLE-DIGIT GROWTH ON SALES FROM DEVELOPMENT AND MANUFACTURING SERVICES TO THIRD PARTIES

* SAID PLANS IN 2019 TO GET NEW COMMERCIAL PARTNER FOR ZALMOXIS AND TO START PHASE I/II CLINICAL STUDY ON HAEMATOLOGICAL TUMORS (AML AND MM) FOR CAR-T CD44V6

* SAID EXPECTS DEVELOPMENT OF NEW CAR PIPELINE, WITH PUBLICATION OF THE FIRST PRE-CLINICAL DATA BY END-2019

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below